Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable,” suggesting that there could be a shift in fund flows towards different ...

In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Proto Labs (PRLB – Research Report), with a price target of $50.00. The company’s shares closed ...

Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a consistent price target of $480.00. According to InvestingPro data ...

On Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...

Cantor Fitzgerald raised the firm’s price target on Protolabs (PRLB) to $50 from $40 and keeps an Overweight rating on the shares. Protolabs reported better-than-expected revenue and adjusted ...

Cantor Fitzgerald analyst M. Prisco now forecasts that the semiconductor company will post earnings of $6.40 per share for the year, down from their previous forecast of $6.55.

Cantor Fitzgerald started coverage on shares of Amentum (NYSE:AMTM – Free Report) in a report issued on Friday, Marketbeat.com reports. The brokerage issued a neutral rating and a $25.00 target ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

We recently published a list of 9 Trending AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at where AST SpaceMobile, Inc. (NASDAQ:ASTS) stands against other ...